Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3136 AL 3150

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

García-Culebras A, Cuartero MI, Peña-Martínez C, Moraga A, Vázquez-Reyes S, de Castro-Millán FJ, Cortes-Canteli M, Lizasoain I, Moro MÁ.

Br J Pharmacol. 2024 Mar;181(6):777-798. doi: 10.1111/bph.16159. Epub 2023 Jul 7.

Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics

Thakkar A, Vora A, Kaur G, Akhtar J.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):2911-2923. doi: 10.1007/s00210-023-02554-x. Epub 2023 Jun 7.

Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy

Jeong WC, Min JY, Kang TG, Bae H.

PLoS One. 2023 Jun 8;18(6):e0286727. doi: 10.1371/journal.pone.0286727. eCollection 2023.

CRISPR-Cas9 in Alzheimer's disease: Therapeutic trends, modalities, and challenges

Chacko L, Chaudhary A, Singh B, Dewanjee S, Kandimalla R.

Drug Discov Today. 2023 Aug;28(8):103652. doi: 10.1016/j.drudis.2023.103652. Epub 2023 Jun 7.

Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development

Burns LH, Pei Z, Wang HY.

Drug Dev Res. 2023 Sep;84(6):1085-1095. doi: 10.1002/ddr.22085. Epub 2023 Jun 8.

Memantine induced encephalopathy in chronic kidney disease: a case report

Prasad P, Bagai S, Khullar D.

Postgrad Med J. 2023 Jun 8;99(1171):498-499. doi: 10.1136/postgradmedj-2022-141646.

Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?

Knopman DS, Hershey L.

Neurology. 2023 Oct 3;101(14):610-620. doi: 10.1212/WNL.0000000000207438. Epub 2023 Jun 9.

Cognitive Deficits in Aging Related to Changes in Basal Forebrain Neuronal Activity

Chaves-Coira I, García-Magro N, Zegarra-Valdivia J, Torres-Alemán I, Núñez Á.

Cells. 2023 May 25;12(11):1477. doi: 10.3390/cells12111477.

Treponema denticola Has the Potential to Cause Neurodegeneration in the Midbrain via the Periodontal Route of Infection-Narrative Review

Pisani F, Pisani V, Arcangeli F, Harding A, Singhrao SK.

Int J Environ Res Public Health. 2023 Jun 4;20(11):6049. doi: 10.3390/ijerph20116049.

Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease

Su M, Nizamutdinov D, Liu H, Huang JH.

Int J Mol Sci. 2023 May 25;24(11):9272. doi: 10.3390/ijms24119272.

Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status

Pinzi L, Bisi N, Sorbi C, Franchini S, Tonali N, Rastelli G.

Molecules. 2023 Jun 4;28(11):4544. doi: 10.3390/molecules28114544.

Insights into prevention mechanisms of bioactive components from healthy diets against Alzheimer's disease

Wang J, Yu Z, Peng Y, Xu B.

J Nutr Biochem. 2023 Sep;119:109397. doi: 10.1016/j.jnutbio.2023.109397. Epub 2023 Jun 8.

TREM2, microglial and ischemic stroke

Wang H, Li X, Wang Q, Ma J, Gao X, Wang M.

J Neuroimmunol. 2023 Aug 15;381:578108. doi: 10.1016/j.jneuroim.2023.578108. Epub 2023 May 16.

Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs

Niu Y, Lin P.

Drug Discov Today. 2023 Aug;28(8):103665. doi: 10.1016/j.drudis.2023.103665. Epub 2023 Jun 9.

Animal models of Alzheimer's disease: An originof innovativetreatments and insight to the disease's etiology

Chavan RS, Supalkar KV, Sadar SS, Vyawahare NS.

Brain Res. 2023 Sep 1;1814:148449. doi: 10.1016/j.brainres.2023.148449. Epub 2023 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias